Study

EORTC-1408-BCG

Aiming to Understand the MOlecular Aberrations in Metastatic Breast Cancer

Study documentation Back to result

Trial Status

Recruiting

Dates

Date of activation: 01-Apr-2014
Date Step1 close: 01-Mar-2021

Data management at EORTC

No

Design

Cohort
Not randomized / N.A.

Targeted Sample size

EORTC Groups: 300 - All Groups: 1300

Study Staff

  • Fatima Cardoso (Study Coordinator), Centre Antoine Lacassagne, NICE CEDEX 2
  • Hanne Locy (Project Manager), EORTC Headquarters, Brussels
  • Sandrine Marreaud (Clinical Research Physician), EORTC Headquarters, Brussels
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Sandrine Rivrain (Pharmacovigilance Manager), EORTC Headquarters, Brussels
  • Jelle Stans (Regulatory Affairs Manager), EORTC Headquarters, Brussels
  • Jessica Berger (Clinical Research Associate/Monitor), EORTC Headquarters, Brussels
  • Luminita Copaceanu (Lead CRA), EORTC Headquarters, Brussels
  • Christine Bourguignon (Clinical Operations Assistant), EORTC Headquarters, Brussels
  • Lucy Sepulveda (Regulatory Affairs Administrator), EORTC Headquarters, Brussels

Type of cancer

  • Breast

Participating groups

  • EORTC Breast Cancer Group
  • Breast International Group
  • ETOP IBCSG Partners Foundation
  • Institut Jules Bordet

Recruiting centers

  • C.H.U. Sart-Tilman (Liege, Belgium)
  • CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
  • Centre Hospitalier De Luxembourg (Luxembourg, Luxembourg)
  • Champalimaud Clinical Center (Lisboa, Portugal)
  • Cliniques Universitaires Saint-Luc (Brussels, Belgium)
  • Grand Hopital de Charleroi - Site Les Viviers (Gilly, Belgium)
  • Institut Jules Bordet (Anderlecht, Belgium)
  • NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom)
  • NHS Lothian - Western General Hospital (Edinburgh, United Kingdom)
  • U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)

Protocol summary

http://clinicaltrials.gov/study/NCT02102165

NCT number

NCT02102165